Fraser Symmans explains how ctDNA is replacing CTCs to monitor breast cancer, detect mutations and track minimal residual ...

As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit takes a look at the latest in early detection blood tests ...

Major paradigm shift incorporates five-year risk assessment and identifies increased-risk women beginning at age 35 BOSTON, April 14, 2026 (GLOBE NEWSWIRE) -- Clairity, Inc. announces the National ...

Unlock the latest liquid biopsy market data. Explore growth drivers, precision oncology shifts, and the tech fueling ...

Detection performance remained consistent across sex and age, unlike the variability seen with AFP alone.

A CRISPR system detects rare cancer mutations in blood with single-nucleotide precision, outperforming ddPCR through engineered RNA guides and isothermal amplification. (Nanowerk Spotlight) Hidden ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...

Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in ...

First, the good news. Among Americans under 50, the overall cancer mortality has plummeted by 44% over the last ...